These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32882179)

  • 1. Valproic Acid Thermally Destabilizes and Inhibits SpyCas9 Activity.
    Cheng X
    Mol Ther; 2020 Dec; 28(12):2635-2641. PubMed ID: 32882179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing.
    Park H; Shin J; Choi H; Cho B; Kim J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32532133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies.
    Allemailem KS; Almatroudi A; Rahmani AH; Alrumaihi F; Alradhi AE; Alsubaiyel AM; Algahtani M; Almousa RM; Mahzari A; Sindi AAA; Dobie G; Khan AA
    Int J Nanomedicine; 2024; 19():5335-5363. PubMed ID: 38859956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytically Enhanced Cas9 through Directed Protein Evolution.
    Hand TH; Roth MO; Smith CL; Shiel E; Klein KN; Gilbert DM; Li H
    CRISPR J; 2021 Apr; 4(2):223-232. PubMed ID: 33876948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
    Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
    Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent CRISPR-Cas9 inhibitors from
    Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
    Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
    Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yourik P; Fuchs RT; Mabuchi M; Curcuru JL; Robb GB
    RNA; 2019 Jan; 25(1):35-44. PubMed ID: 30348755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
    Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
    Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
    Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
    J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.
    Cerchione D; Loveluck K; Tillotson EL; Harbinski F; DaSilva J; Kelley CP; Keston-Smith E; Fernandez CA; Myer VE; Jayaram H; Steinberg BE
    PLoS One; 2020; 15(4):e0231716. PubMed ID: 32298334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
    Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
    Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The final cut: Cas9 editing.
    Taylor DW
    Nat Struct Mol Biol; 2019 Aug; 26(8):669-670. PubMed ID: 31285603
    [No Abstract]   [Full Text] [Related]  

  • 20. A glance at genome editing with CRISPR-Cas9 technology.
    Barman A; Deb B; Chakraborty S
    Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.